U.S. Physical Therapy's 15min chart shows KDJ Death Cross, Bearish Marubozu pattern.
ByAinvest
Wednesday, Aug 20, 2025 9:48 am ET1min read
USPH--
According to the 15-minute chart, a bearish KDJ Death Cross signal and a Bearish Marubozu pattern were observed on August 20, 2025, at 09:45 [1]. These technical indicators suggest that the momentum of the stock price is shifting towards a downward trajectory, potentially leading to further decline in value. Sellers currently hold control of the market, indicating a strong likelihood that this bearish momentum will continue.
Despite the recent technical indicators, U.S. Physical Therapy reported strong earnings for the second quarter of 2025. The company posted quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.71 per share, representing a quarterly earnings surprise of +14.08% [1]. Revenues for the quarter were $197.34 million, surpassing the Zacks Consensus Estimate by 3.78% [1]. Over the last four quarters, USPH has consistently surpassed consensus EPS estimates three times.
However, the stock has lost about 18.8% since the beginning of the year, compared to the S&P 500's gain of 7.1%. The company's performance relative to its peers in the Medical - Outpatient and Home Healthcare industry, which ranks in the top 28% of Zacks industries, is a factor to consider [1]. The Zacks Rank, which considers earnings estimate revisions, currently stands at #3 (Hold) for USPH, indicating that the stock is expected to perform in line with the market in the near future. However, the recent technical indicators suggest a potential downturn in the stock's momentum.
Investors should closely monitor the company's earnings outlook and management commentary on the earnings call to gauge the sustainability of the stock's price movement. The current consensus EPS estimate for the coming quarter is $0.65, and for the current fiscal year, it is $2.49 [1].
In conclusion, while U.S. Physical Therapy has shown strong earnings performance, the technical indicators suggest a potential downturn in the stock's momentum. Investors should remain vigilant and consider the company's earnings outlook and industry performance before making investment decisions.
References:
[1] https://www.nasdaq.com/articles/us-physical-therapy-usph-tops-q2-earnings-and-revenue-estimates
US Physical Therapy's 15-minute chart has exhibited a KDJ Death Cross and a Bearish Marubozu at 08/20/2025 09:45, which suggests a shift in momentum towards the downside. This bearish signal indicates a potential further decrease in stock price, as sellers are currently in control of the market. The bearish momentum is likely to persist.
U.S. Physical Therapy's (USPH) 15-minute chart has exhibited a KDJ Death Cross and a Bearish Marubozu at 08/20/2025 09:45, suggesting a significant shift in momentum towards the downside. This bearish signal indicates a potential further decrease in stock price, as sellers are currently in control of the market. The bearish momentum is likely to persist.According to the 15-minute chart, a bearish KDJ Death Cross signal and a Bearish Marubozu pattern were observed on August 20, 2025, at 09:45 [1]. These technical indicators suggest that the momentum of the stock price is shifting towards a downward trajectory, potentially leading to further decline in value. Sellers currently hold control of the market, indicating a strong likelihood that this bearish momentum will continue.
Despite the recent technical indicators, U.S. Physical Therapy reported strong earnings for the second quarter of 2025. The company posted quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.71 per share, representing a quarterly earnings surprise of +14.08% [1]. Revenues for the quarter were $197.34 million, surpassing the Zacks Consensus Estimate by 3.78% [1]. Over the last four quarters, USPH has consistently surpassed consensus EPS estimates three times.
However, the stock has lost about 18.8% since the beginning of the year, compared to the S&P 500's gain of 7.1%. The company's performance relative to its peers in the Medical - Outpatient and Home Healthcare industry, which ranks in the top 28% of Zacks industries, is a factor to consider [1]. The Zacks Rank, which considers earnings estimate revisions, currently stands at #3 (Hold) for USPH, indicating that the stock is expected to perform in line with the market in the near future. However, the recent technical indicators suggest a potential downturn in the stock's momentum.
Investors should closely monitor the company's earnings outlook and management commentary on the earnings call to gauge the sustainability of the stock's price movement. The current consensus EPS estimate for the coming quarter is $0.65, and for the current fiscal year, it is $2.49 [1].
In conclusion, while U.S. Physical Therapy has shown strong earnings performance, the technical indicators suggest a potential downturn in the stock's momentum. Investors should remain vigilant and consider the company's earnings outlook and industry performance before making investment decisions.
References:
[1] https://www.nasdaq.com/articles/us-physical-therapy-usph-tops-q2-earnings-and-revenue-estimates
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet